Comparison of drug and cell-based delivery-Engineering adult Mesenchymal stem cells to deliver human Erythropoietin

Gene Therapy and Molecular Biology

Volumn 13, Issue 2, 2009, Pages 321-330

  Wang, Gang ^a   Liu, Linda N ^a   Lee, Keunmyoung ^a   Buyaner, Diana ^a   Hendricks, Kyle ^a   Kalfoglou, Creton S ^b   Bohnlein, Ernst ^b   Junker, Uwe ^b   Mosca, Joseph D ^a  

^a OSIRIS THERAPEUTICS INC   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Cell based therapy; Erythropoietin; Gene delivery; Hematocrit; Mesenchymal stems cells

Indexed keywords

ANIMALIA; MUS;

EID: 77649282623     PISSN: 15299120     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Allay JA, Dennis JE, Haynesworth SE, Majumdar MK, Clapp DW, Shultz LD, Caplan AI, Gerson SL (1997) LacZ and interleukin-3 expression in vivo after retroviral transduction of marrow-derived human osteogenic mesenchymal progenitors. Hum Gene Ther 8, 1417-1427.
2. Bartholomew A, Patil S, Mackay A, Nelson M, Buyaner D, Hardy W, Mosca J, Sturgeon C, Siatskas M, Ferrer K, Deans R, Moseley A, Hoffman R, Devine SM (2001) Baboon Mesenchymal Stem Cells Can Be Genetically Modified To Secrete Human Erythropoietin In Vivo. Hum Gene Ther 12, 1527-1541.
3. Boyce FM and Bucher NL (1996) Baculovirus-mediated gene transfer into mammalian cells. Proc Natl Acad Sci USA 93, 2348-2352.
4. Bruder SP, Kraus KH, Goldberg VM, Kadiyala S (1998) The Effect of Implants Loaded with Autologous Mesenchymal Stem Cells on the Healing of Canine Segmental Bone Defects. J Bone and Joint Surg 80-A, 985-996.
5. Copland IB, Jolicoeur EM, Gillis MA, Cuerquis J, Eliopoulos N, Annabi B, Calderone A, Tanguay JF, Ducharme A (2008) Coupling erythropoietin secretion to mesenchymal stromal cells enhances their regenerative properties. Cardiovasc Res 79, 405-415.
6. Corradi-Perini C, Southgate TD, Besley GT, Cooper A, Deakin JA, Wraith JE, Fairbairn LJ, Wynn RF, Bellantuono I (2008) Retrovirally-mediated genetic correction of mesenchymal stem cells from patients affected by mucopolysaccharidosis type II (Hunter Syndrome). Gene Ther and Molec Bio 12, 167-174.
7. Daga A, Muraglia A, Quarto R, Cancedda R, Corte G (2002) Enhanced engraftment of EPO-transduced human bone marrow stromal cells transplanted in a 3D matrix in non-conditioned NOD/SCID mice. Gene Ther 9, 915-921.
8. Day CS, Kasemkijwattana C, Menetrey J, Floyd SS Jr, Booth D, Moreland MS, Fu FH, Huard J (1997) Myoblast-mediated gene transfer to the joint. J Orthop Res 15, 894-903.
9. Dhawan J, Pan LC, Pavlath GK, Travis MA, Lanctot AM, Blau HM (1991) Systemic delivery of human growth hormone by injection of genetically engineered myoblasts. Science 254, 1509-1512.
10. Drize NJ, Surin VL, Gan OI, Deryugina EI, Chertkov JL (1992) Gene therapy model for stromal precursor cells of hematopoietic microenvironment. Leukemia 6, 174S-175S.
11. Eliopoulos N, Lejeune L, Martineau D, Galipeau J (2004) Humancompatible collagen matrix for prolonged and reversible systemic delivery of erythropoietin in mice from gene-modified marrow stromal cells. Mol Ther 10, 741-748.
12. Emerich DF, Hammang JP, Baetge EE, Winn SR (1994) Implantation of polymer-encapsulated human nerve growth factor-secreting fibroblasts attenuates the behavioral and neuropathological consequences of quinolinic acid injections into rodent striatum. Exp Neurol 130, 141-150.
13. Erslev AJ (1991) Erythropoietin. N Engl J Med 324, 1339-1344. Evans V, Foster H, Graham IR, Foster K, Athanasopoulos T, Simons JP, Dickson G, Owen JS (2008) Human apolipoprotein E expression from mouse skeletal muscle by electrotransfer of nonviral DNA (plasmid) and pseudotyped recombinant adenoassociated virus (AAV2/7). Hum Gene Ther 19, 569-578.
14. Fenjves ES, Smith J, Zaradic S, Taichman LB (1994) Systemic delivery of secreted protein by grafts of epidermal keratinocytes: prospects for keratinocyte gene therapy. Hum Gene Ther 5, 1241-1248.
15. Fisher LJ, Raymon HK, Gage FH (1993) Cells engineered to produce acetylcholine: therapeutic potential for Alzheimer's disease. Ann NY Acad Sci 695, 278-284.
16. Forestell SP, Dando JS, Chen J, de Vries P, Böhnlein E, Rigg RJ (1997) Novel retroviral packaging cell lines: complementary tropisms and improved vector production for efficient gene transfer. Gene Ther 4, 600-610.
17. Frietsch T, Maurer MH, Vogel J, Gassmann M, Kuschinsky W, Waschke KF (2007) Reduced cerebral blood flow but elevated cerebral glucose metabolic rate in erythropoietin overexpression transgenic mice with excessive erythrocytosis. J Cereb Blood Flow Metab 27, 469-476.
18. Garver RI Jr, Chytil A, Courtney M, Crystal RG (1987) Clonal gene therapy: transplanted mouse fibroblast clones express human alpha 1-antitrypsin gene in vivo. Science 237, 762-764.
19. Anderson WF, Hall FL (1997) Capture and expansion of bone marrow-derived mesenchymal progenitor cells with a transforming growth factor-beta1-von Willebrand's factor fusion protein for retrovirus-mediated delivery of coagulation factor IX. Hum Gene Ther 8, 1385-1394.
20. Griffitt W, Glick RP, Lichtor T, Cohen EP (1998) Survival and toxicity of an allogeneic cytokine-secreting fibroblast vaccine in the central nervous system. Neurosurgery 42, 335-340.
21. Grossman M and Wilson JM (1993) Retroviruses: delivery vehicle to the liver. Curr Opin Genet Dev 3, 110-114.
22. Hardy SA, Maltman DJ, Przyborski SA (2008) Mesenchymal stem cells as mediators of neutral differentiation. Curr Stem Cell Res Ther 3, 43-52.
23. Harris CT and Cooper LF (2004) Comparison of bone graft matrices for human mesenchymal stem cell-directed osteogenesis. J Biomed Mater Res 68A, 747-755.
24. Haynesworth SE, Goshima J, Goldberg VM, Caplan AI (1992) Characterization of cells with osteogenic potential from human marrow. Bone 13, 81-88.
25. Huang NF and Li S (2008) Mesenchymal stem cells for vascular regeneration. Regen Med 3, 877-892.
26. Ito Y, Shiroyama K, Yoshimitsu J, Ohashi Y, Sugioka N, Takada K (2007) Pharmacokinetic and pharmacodynamic studies following percutsneous absorption of erythropoietin micropiles to rats. J Control Release 121, 176-180.
27. Jaiswal RK, Jaiswal N, Bruder SP, Mbalaviele G, Marshak DR, Pittenger MF (2000) Adult Human Mesenchymal Stem Cell Differentiation to the Osteogenic or Adipogenic Lineage Is Regulated by Mitogen-activated Protein Kinase. J Biol Chem 275, 9645-9652.
28. Johnston J, Tazelaar J, Rivera VM, Clackson T, Gao GP, Wilson JM (2003) Regulated expression of erythropoietin from an AAV vector safely improves the anemia of beta-thalassemia in a mouse model. Mol Ther 7, 493-497.
29. Klyushnenkova E, Mosca JD, Zernetkina V, Majumdar MK, Beggs KJ, Simonetti DW, Deans RJ, McIntosh KR (2005) T cell responses to allogeneic human mesenchymal stem dells: immunogenicity, tolerance, and suppression. J Biomed Sci 12, 47-57.
30. Ledley FD, Grenett HE, McGinnis-Shelnutt M, Woo SL (1986) Retroviral-mediated gene transfer of human phenylalanine hydroxylase into NIH 3T3 and hepatoma cells. Proc Natl Acad Sci USA 83, 409-413.
31. Ledley FD, Darlington GJ, Hahn T, Woo SL (1987) Retroviral gene transfer into primary hepatocytes: implications for genetic therapy of liver-specific functions. Proc Natl Acad Sci USA 84, 5335-5339.
32. Lee K, Majumdar MK, Buyaner D, Hendricks JK, Pittenger MF, Mosca JD (2001) Human Mesenchymal Stem Cells Maintain Transgene Expression during Expansion and Differentiation. Mol Ther 3, 857-866.
33. Maiese K, Chong ZZ, Hou J, Shang YC (2008) Erythropoietin and oxidative stress. Curr Neurovasc Res 5, 125-142.
34. Majumdar MK, Thiede MA, Moorman M, Gerson SL (1998) Phenotypic and Functional Comparison of Cultures of Marrow-Derived Mesenchymal Stem Cells and Stromal Cells. J Cell Phys 176, 56-77.
35. Marx JC, Allay JA, Persons DA, Nooner SA, Hargrove PW, Kelly PF, Vanin EF, Horwitz EM (1999) High-efficiency transduction and long-term gene expression with a murine stem cell retroviral vector encoding the green fluorescent protein in human marrow stromal cells. Hum Gene Ther 10, 1163-1173.
36. Mok PL, Cheong SK, Leong CF, Othman A (2008) In vitro expression of erythropoietin by transfected human mesenchymal stromal cells. Cytotherapy 10,116-124.
37. Morgan JR, Barrandon Y, Green H, Mulligan RC (1987) Expression of an exogenous growth hormone gene by transplantable human epidermal cells. Science 237, 1476-1479.
38. Mosca JD, Hendricks K, Buyaner D, Davis-Sproul J, Chuang L, Majumdar MK, Chopra R, Thiede MA, Junker U, Rigg RJ, Forestell SP, Böhnlein E, Storb R, Sandmaier BM (2000) Mesenchymal stem cells as vehicles for gene delivery: transduction of eight species and biodistribution in a canine model. Clinical Ortho and Related Res 379S, S71-S90.
39. Mosca JD, Chang YN, Williams G (2007) Antigen-presenting particle technology using inactivated surface-engineered viruses: induction of immune responses against infectious agents. Retrovirology 4, 32-49.
40. Nauta AJ and Fibbe WE (2007) Immunomodulatory properties of mesenchymal stromal cells. Blood 110, 3499-3506.
41. Noguchi CT, Wang L, Rogers HM, Teng R, Jia Y (2008) Survival and proliferative roles of erythropoietin beyond the erythroid lineage. Expert Rev Mol Med 10, e36.
42. Nolta JA, Hanley MB, Kohn DB (1994) Sustained human hematopoiesis in immunodeficient mice by cotransplantation of marrow stroma expressing human interleukin-3: analysis of gene transduction of long-lived progenitors. Blood 83, 3041-3051.
43. Ohgushi H and Caplan AI (1999) Stem cell technology and bioceramics: from cell to gene engineering. J Biomed Mater Res 48, 913-927.
44. Palmer TD, Hock RA, Osborne WR, Miller AD (1987) Efficient retrovirus-mediated transfer and expression of a human adenosine deaminase gene in diploid skin fibroblasts from an adenosine deaminase-deficient human. Proc Natl Acad Sci USA 84, 1055-1059.
45. Partridge KA and Oreffo RO (2004) Gene delivery in bone tissue engineering: progress and prospects using viral and nonviral strategies. Tissue Eng 10, 295-307.
46. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284, 143-147.
47. Pittenger MF and Martin BJ (2004) Mesenchymal stem cells and their potential as cardiac therapeutics. Circ Res 95, 9-20.
48. Ponce S, Orive G, Hernandez RM, Gascon AR, Canals JM, Munoz MT, Pedraz JL (2006) In vivo evaluation of EPO-secreting cells immobilized in different alginate-PLL microcapsules. J Control Release 116, 28-34.
49. Redondo PA, Alvarez AI, Diez C, Fernandez-Rojo F, Prieto JG (1995) Physiological response to experimentally induced anemia in rats: a comparative study. Lab Anim Sci 45, 578-583.
50. Scheidemann F, Loser M, Niedermeier A, Kromminga A, Therrien J-P, Vogel J, Pfutzner W (2008) The skin as a biofactory for systemic secretion of erythropoietin: potential of genetically modified keratinocytes and fibroblasts. Exp Dermatol 17,481-488.
51. Shultz LD, Schweitzer PA, Christianson SW, Gott B, Schweitzer IB, Tennent B, McKenna S, Mobraaten L, Rajan TV, Greiner DL, Leiter EH (1995) Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice. J Immunol 154, 180-191.
52. Sorge J, Kuhl W, West C, Beutler E (1987) Complete correction of the enzymatic defect of type I Gaucher disease fibroblasts by retroviral-mediated gene transfer. Proc Natl Acad Sci USA 84, 906-909.
53. Sun L, Xu L, Chang H, Henry FA, Miller RM, Harmon JM, Nielsen TB (1997) Transfection with aFGF cDNA improves wound healing. J Invest Dermatol 108, 313-318.
54. Taichman LB (1999) Systemic replacement therapy from genetically modified epidermal keratinocytes. Proc Assoc Am Physicians 111, 206-210.
55. Takacs K, Du Roure C, Nabarro S, Dillon N, McVey JH, Webster Z, MacNeil A, Bartok I, Higgins C, Gray D, Merkenschlager M, Fisher AG (2004) The regulated long-term delivery of therapeutic proteins by using antigen-specific B lymphocytes. Proc Natl Acad Sci USA 101, 16298-16303.
56. Vanguri P, Tao L, Pittenger M, McIntosh KR (1999) Characterization of human mesenchymal stem cells differentiated into adipocytes for tissue-specific antigen presentation. Exper Hemato 27, 45.
57. Wolff JA, Yee JK, Skelly HF, Moores JC, Respess JG, Friedmann T, Leffert H (1987) Expression of retrovirally transduced genes in primary cultures of adult rat hepatocytes. Proc Natl Acad Sci USA 84, 3344-3348.
58. Yanay O, Barry SC, Flint LY, Brzezinski M, Barton RW, Osborne WR (2003) Long-term erythropoietin gene expression from transduced cells in bioisolator devices. Hum Gene Ther 14, 1587-1593.
59. Zwezdaryk KJ, Coffelt SB, Figueroa YG, Liu J, Phinney DG, LaMarca HL, Florez L, Morris CB, Hoyle GW, Scandurro AB (2007) Erythropoietin, a hypoxia-regulated factor, elicits a proangiogenic program in human mesenchymal stem cells, Exp Hemato 35, 640-652